Home Biosimilar Antibodies Others Others Prezalumab (Anti-B7-H2 / ICOSL / CD275)
For research use only. Not for use in humans.

Prezalumab (Anti-B7-H2 / ICOSL / CD275)

Synonyms: AMG 557

Prezalumab (Anti-B7-H2 / ICOSL / CD275) is a human IgG2 monoclonal antibody targeting ICOSL and BAFF. It demonstrates studies for systemic lupus erythematosus arthritis. It is used in the research of Sjogren's syndrome cutaneous lupus erythematosus, psoriasis and systemic lupus erythematosus (SLE).MW :145.5 KD.

Prezalumab (Anti-B7-H2 / ICOSL / CD275)

Quality Control

Batch: A258301 Purity: 99% Protein concentration: 11.65mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Prezalumab (Anti-B7-H2 / ICOSL / CD275) is a human IgG2 monoclonal antibody targeting ICOSL and BAFF. It demonstrates studies for systemic lupus erythematosus arthritis. It is used in the research of Sjogren's syndrome cutaneous lupus erythematosus, psoriasis and systemic lupus erythematosus (SLE).MW :145.5 KD.

Product Details

CAS No. 1523164-68-2
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.